- BI/Lilly move to shore up Trajenta USP
- New EU HTA guideline tackles thorny issue of comparators
- Price cuts loom on latest pre-AMNOG call up
- No hope for BI/Lilly's Trajenta in Germany, but will prescribers care?
ONLY 0 DAY LEFT
|Stay close to your market. Renew online now to ensure uninterrupted access to:|
|SCRIP Intelligence's news and expert commentary|
|Market Data and Company Analysis (SCRIP 100, SCRIP Asia 100)|
|The Ask the Analyst Service...and more.|
Please remember to quote your order number and customer number.
You can also renew by calling: +44 (0)20 7017 5540.